110 related articles for article (PubMed ID: 7680736)
1. Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells.
Rhedin AS; Tidefelt U; Jönsson K; Lundin A; Paul C
Leuk Res; 1993 Mar; 17(3):271-6. PubMed ID: 7680736
[TBL] [Abstract][Full Text] [Related]
2. In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations.
Tidefelt U; Sundman-Engberg B; Rhedin AS; Paul C
Eur J Haematol; 1989 Nov; 43(5):374-84. PubMed ID: 2482193
[TBL] [Abstract][Full Text] [Related]
3. In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay.
Möllgård L; Tidefelt U; Sundman-Engberg B; Löfgren C; Paul C
Leuk Res; 2000 May; 24(5):445-52. PubMed ID: 10785267
[TBL] [Abstract][Full Text] [Related]
4. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
Kravtsov VD; Greer JP; Whitlock JA; Koury MJ
Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366
[TBL] [Abstract][Full Text] [Related]
5. Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo.
Sundman-Engberg B; Tidefelt U; Liliemark J; Paul C
Cancer Chemother Pharmacol; 1990; 25(4):252-6. PubMed ID: 2295112
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.
Kurbacher CM; Cree IA; Brenne U; Bruckner HW; Kurbacher JA; Mallmann P; Andreotti PE; Krebs D
Breast Cancer Res Treat; 1996; 41(2):161-70. PubMed ID: 8944334
[TBL] [Abstract][Full Text] [Related]
7. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of adenosine triphosphate bioluminescence assay for tumor in vitro chemosensitivity testing].
Liu S; Peng Z; Lou J; Wang H; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):330-3. PubMed ID: 12545824
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER
Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
11. In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
Klumper E; Pieters R; Kaspers GJ; Huismans DR; Loonen AH; Rottier MM; van Wering ER; van der Does-van den Berg A; Hählen K; Creutzig U
Leukemia; 1995 Nov; 9(11):1864-9. PubMed ID: 7475276
[TBL] [Abstract][Full Text] [Related]
12. In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.
Santini V; Bernabei PA; Silvestro L; Dal Pozzo O; Bezzini R; Viano I; Gattei V; Saccardi R; Ferrini PR
Hematol Oncol; 1989; 7(4):287-93. PubMed ID: 2737608
[TBL] [Abstract][Full Text] [Related]
13. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
Nogaki M; Ichihashi H
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
[TBL] [Abstract][Full Text] [Related]
14. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
15. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ
Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616
[TBL] [Abstract][Full Text] [Related]
16. In vitro chemosensitivity testing in acute leukemias. Results of a retrospective study.
Lepri E; Liberati M; Menconi E; Santucci A; Piselli F; Barzi A
Anticancer Res; 1990; 10(6):1735-8. PubMed ID: 2285251
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.
Kuzmits R; Aiginger P; Müller MM; Steurer G; Linkesch W
Clin Sci (Lond); 1986 Jul; 71(1):81-8. PubMed ID: 3458552
[TBL] [Abstract][Full Text] [Related]
18. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
19. Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.
Minn H; Kangas L; Knuutila V; Paul R; Sipilä H
Res Exp Med (Berl); 1991; 191(1):27-35. PubMed ID: 2034887
[TBL] [Abstract][Full Text] [Related]
20. Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo.
Sundman-Engberg B; Tidefelt U; Gruber A; Paul C
Leuk Res; 1993 Apr; 17(4):347-52. PubMed ID: 8487583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
